Literature DB >> 22935217

Bisphosphonates use in children.

Judith F Sebestyen1, Tarak Srivastava, Uri S Alon.   

Abstract

Bisphosphonates are synthetic analogues of pyrophosphate that inhibit bone resorption by their action on osteoclasts. In recent years, bisphosphonates have been used in children for treatment of a growing number of disorders associated primarily with generalized or localized osteoporosis, genetic and acquired metabolic bone diseases, heterotopic calcifications in soft tissues, and for hypercalcemia. In this review, the authors address the role of and experience with bisphosphonate therapy in disorders of childhood.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22935217     DOI： 10.1177/0009922812452118

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN： 0009-9228            Impact factor:   1.168


  17 in total

Review 1.  Hypercalcemia: a consultant's approach.

Authors:  Ari Auron; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2017-09-06       Impact factor: 3.714

2.  Effect of Low-Magnitude, High-Frequency Mechanical Stimulation on BMD Among Young Childhood Cancer Survivors: A Randomized Clinical Trial.

Authors:  Rona J Mogil; Sue C Kaste; Robert J Ferry; Melissa M Hudson; Daniel A Mulrooney; Carrie R Howell; Robyn E Partin; Deo K Srivastava; Leslie L Robison; Kirsten K Ness
Journal:  JAMA Oncol       Date:  2016-07-01       Impact factor: 31.777

Review 3.  Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy.

Authors:  Jennifer M Bell; Michael D Shields; Janet Watters; Alistair Hamilton; Timothy Beringer; Mark Elliott; Rosaline Quinlivan; Sandya Tirupathi; Bronagh Blackwood
Journal:  Cochrane Database Syst Rev       Date:  2017-01-24

4.  Primary osteoporosis in children.

Authors:  Lay Ong Tan; Soo Yen Lim; Rashida Farhad Vasanwala
Journal:  BMJ Case Rep       Date:  2017-09-01

Review 5.  Bone mineral density deficits and fractures in survivors of childhood cancer.

Authors:  Carmen L Wilson; Kirsten K Ness
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

6.  Effect of alendronate on the mandible and long bones: an experimental study in vivo.

Authors:  Sharon R Oyhanart; Natalia D Escudero; Patricia M Mandalunis
Journal:  Pediatr Res       Date:  2015-09-02       Impact factor: 3.756

Review 7.  Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy.

Authors:  Peter Vestergaard
Journal:  Paediatr Drugs       Date:  2015-04       Impact factor: 3.022

8.  Radiographic and MR Imaging Findings of the Spine after Bisphosphonate Treatment, in a Child with Idiopathic Juvenile Osteoporosis.

Authors:  Olympia Papakonstantinou; Maria Sakalidou; Erato Atsali; Vasiliki Bizimi; Maria Mendrinou; Efthymia Alexopoulou
Journal:  Case Rep Radiol       Date:  2015-01-20

9.  Body composition and bone health in long-term survivors of acute lymphoblastic leukaemia in childhood and adolescence: the protocol for a cross-sectional cohort study.

Authors:  Ronald Barr; Trishana Nayiager; Christopher Gordon; Christopher Marriott; Uma Athale
Journal:  BMJ Open       Date:  2015-01-20       Impact factor: 2.692

10.  Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density.

Authors:  Se Won Lim; Ju Hyun Ahn; Aery Choi; Wan Hyeong Cho; Jun Ah Lee; Dong Ho Kim; Ju-Hee Seo; Jung Sub Lim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2016-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.